1. Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus.
- Author
-
Hatano M, Yajima N, Yanai R, Ishii S, Tsujimoto Y, Azuma T, Atsumi T, Kaneko Y, Kameda H, Kuwana M, Tanaka Y, Nakagawa S, Nakajima A, Hiramatsu Y, Fujita D, Miyamae T, and Murashima A
- Subjects
- Female, Humans, Pregnancy, Parturition, Lupus Erythematosus, Systemic diagnosis, Pregnancy Complications diagnosis, Quality Indicators, Health Care
- Abstract
Objectives: A quality indicator (QI) for the treatment of systemic lupus erythematosus (SLE) during pregnancy and childbirth that is useful for sharing standard treatment policies has not yet been developed. This study aimed to develop a QI for SLE associated with pregnancy and childbirth., Methods: To identify candidate QIs, we conducted a systematic literature review on the development of QIs for SLE related to pregnancy and childbirth and on clinical practice guidelines. Candidate QI items were extracted from the final selected articles, and a first evaluation, panel meeting, and second evaluation were conducted to determine whether the candidate items were appropriate as QIs. Items for which all panel members reached a consensus were designated pregnancy and childbirth-related SLE QIs., Results: Four articles on SLE QI development and 28 practice guidelines were listed through abstract/text screening. Based on these studies, 52 candidate QIs were extracted that were limited to items related to pregnancy and childbirth and 41 items were selected on which all panel members agreed., Conclusion: We developed pregnancy-related SLE QIs using the RAND/UCLA method and selected 41 items, which could be used clinically., (© Japan College of Rheumatology 2024. Published by Oxford University Press.)
- Published
- 2024
- Full Text
- View/download PDF